Millipore has acquired European-based services provider BioAnaLab, extending the company's biopharmaceutical services business into Europe.

"Our acquisition of BioAnaLab will allow us to build on our reputation as a trusted outsource partner in North America by establishing a presence in the fast-growing European biotech market," said Jonathan DiVincenzo, president of the company’s bioscience division, in a statement. "BioAnaLab will add cGMP support testing capabilities to our portfolio, a solid customer base and a team of services professionals with expertise in emerging scientific disciplines."

BioAnaLab current offerings include assay transfer/development, validation and sample analysis and vaccine services. Millipore's experience in biomarker analytical services is expected to strengthen BioAnaLab's current offerings in that area.

More information in Millpore can be found at www.millipore.com
and on BioAnaLab at www.bioanalab.com